Press-release for stocks for GILD

Prices are updated after-hours

Gilead’s Bold Ambition of Transforming Triple-Negative Breast Cancer Treatment to Be Highlighted With New Data at SABCS
Published: 2021-11-29 (Crawled : 16:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 6.4M

| -4.44% | O: 0.74% H: 0.0% C: 0.0%
treatment cancer negative breast cancer

Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients
Published: 2021-11-29 (Crawled : 15:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 6.4M

| -4.44% | O: 0.74% H: 0.0% C: 0.0%
AMZN | $179.22 -1.14% -1.15% 30M

| -94.77% | O: 1.2% H: 0.0% C: 0.0%
liver collaboration

| -4.44% | O: 0.74% H: 0.0% C: 0.0%
GTHX | $4.16 -2.8% -2.88% 690K

| -68.6% | O: 0.75% H: 0.82% C: -6.28%
phase 2 trilaciclib antibody drug trial therapeutics

| -4.44% | O: 0.74% H: 0.0% C: 0.0%
GTHX | $4.16 -2.8% -2.88% 690K

| -68.6% | O: 0.75% H: 0.82% C: -6.28%
trodelvy phase 2 trilaciclib antibody drug trial therapeutics

64%

36%

AGBA | News | $1.02 155.0% 57.94% 120M

ZCMD | $2.86 108.76% 52.1% 2.3M

INVO | $1.555 104.6% 51.13% 5M

ISPC | $0.437 105.16% 49.53% 37M

WLGS | News | $0.92 84.0% 45.65% 1.6M

OST | $0.499 21.38% 45.26% 1.9M

XPON | News | $3.1 60.62% 37.74% 17M

TIRX | $0.7 44.39% 30.74% 58M

BNTC | News | $6.92 44.17% 30.64% 3.5M

GGE | $0.035 19.86% 29.3% 64M

Save your searches and get alerts when important news are released.